3billion
Seoul
About 3billion
3billion was founded with the goal of ending the diagnostic odyssey of rare disease patients through comprehensive genetic testing. It has reduced the amount of time and cost that was previously required for genome interpretation by using bioinformatics and machine learning technology, making genome-scale rare disease genetic testing affordable for patients in need. The company was established in 2016 and is headquartered in Seoul, South Korea.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $25.7M
- Funding stage: IPO
- Last round: Series C (Mar 2021)
- Ticker: kosdaq:394800
- Website: 3billion.io
- Phone: [email protected]
Industries & Categories
Bioinformatics, Genetics, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/3billion-18269 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.